USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE Read more about USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE New Zealand595262Filed on 2011-09-19
MIR 204, MIR 211, Their Anti-MIRS, and Therapeutic Uses of Same Read more about MIR 204, MIR 211, Their Anti-MIRS, and Therapeutic Uses of Same US Patent 8,710,026Filed on 2013-05-16
Methods of Producing and Using Regulatory B-Cells Read more about Methods of Producing and Using Regulatory B-Cells Patent Cooperation TreatyPCT/US2013/036175Filed on 2013-04-11
Methods of Treatment Using Sterculic Acid Read more about Methods of Treatment Using Sterculic Acid US Patent 8,993,626Filed on 2012-12-19
Methods of Treatment Using Sterculic Acid Read more about Methods of Treatment Using Sterculic Acid European Patent11731200.9Filed on 2011-06-24
Methods of Using Sterculic Acid Read more about Methods of Using Sterculic Acid Canada2803923Filed on 2011-06-24
Methods of Treatment Using Sterculic Acid Read more about Methods of Treatment Using Sterculic Acid Australia2011270754Filed on 2011-06-24
Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice Read more about Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice US Application 13/581,884Filed on 2012-11-07
Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice Read more about Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice Japan2012-555540Filed on 2012-08-30
Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice Read more about Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice Israel221469Filed on 2011-02-27